Non-Alcoholic Fatty Liver Disease

Evolution of Medicine Podcast

Approximately one quarter (25%) of the United States population has non-alcoholic fatty liver disease (NAFLD). Patients with this reversible condition have accumulated fat in their liver cells. Over time, this creates inflammation and if left unaddressed, will eventually lead to permanent scarring or cirrhosis of the liver. The condition is highly associated with metabolic syndrome and insulin resistance, and it is projected to become the leading cause of liver transplantation by 2030.

Our guest on this episode of the podcast is Elizabeth Boham, MD. She is trained as both a medical doctor and nutritionist, teaches with the IFM and is the Medical Director for the UltraWellness Center.

She joins James to share:

• Which symptoms and test results are red flags for NAFLD

• That toxins and alcohol significantly impact liver health and metabolic syndrome

• How lifestyle and nutrition strategies will help patients with the condition

• Resources and approaches that will help your patients with cardiometabolic disease

• And much more!